While data are limited (due to the rarity of lymphocytic HES), some authors have suggested that there might be some degree of correlation between the percentage of abnormal T cells (especially CD3− CD4+) and the clinical course (i.e., an increased percentage of abnormal T cells could be associated with poorer control of clinical manifestations). This evidence concerns the gene CD4 and hypereosinophilic syndrome.